Skip to main content Skip to local navigation

Global Strategy Lab awarded $8.7M to create AMR Policy Accelerator

Global Strategy Lab awarded $8.7M to create AMR Policy Accelerator


Published on October 25, 2022

Antimicrobial resistance (AMR) is one of the greatest threats humanity faces today. Decades of use, overuse and misuse of antimicrobials in animals and humans has led to the development of bacteria, viruses, fungi and parasites that no longer respond to lifesaving antimicrobial medicines.

Now a new $8.7-million initiative, based at the Global Strategy Lab at York University, will bridge science and policy to support evidence-informed AMR policymaking around the world. This initiative is led by York Professors Steven J. Hoffman and Susan Rogers Van Katwyk with support from leading York University researchers Professors Mathieu PoirierAdrian ViensTarra Penney and University of Ottawa Professor Patrick Fafard.

The AMR Policy Accelerator is designed to advise the world’s governments, public health institutions and decision-makers on effective and equitable policies to ensure sustainable antimicrobial use for everyone. The AMR Policy Accelerator will undertake rigorous research, develop practical resources and tailor custom advisory services to comprehensively support equitable, evidence-informed policymaking on antimicrobial resistance at the national and global levels.

This initiative has been awarded $8.7 million from the Wellcome Trust, a leading charitable foundation that supports science to solve the urgent health issues facing everyone. To find out more about the AMR Policy Accelerator, visit

About the Global Strategy Lab: Using an intensely interdisciplinary approach, GSL undertakes innovative research to advise governments and public health organizations on how to design laws, policies and institutions that address transnational health threats and make the world a healthier place for everyone.

Based at York University and the University of Ottawa, GSL’s research division focuses on three streams: antimicrobial resistance, global legal epidemiology and public health institutions. GSL’s policy division provides specialized evidence-based advisory services to governments and civil society organizations. For more information, visit

Originally published by Yfile (October 25, 2022).


Global Health & Humanitarianism



Related Work

Global Strategy Lab | Project, Research




Tarra Penney, Faculty Fellow, Faculty of Health Active
Steven J. Hoffman, Dahdaleh Distinguished Chair in Global Governance & Legal Epidemiology Active

You may also be interested in...